These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33647820)

  • 21. Trimethylamine-N-oxide and 5-year mortality: the role of gut microbiota-generated metabolite from the CORE-Thailand cohort.
    Senthong V; Kiatchoosakun S; Wongvipaporn C; Phetcharaburanin J; Sritara P; Phrommintikul A;
    Sci Rep; 2024 Sep; 14(1):21264. PubMed ID: 39261513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism.
    Obeid R; Awwad HM; Rabagny Y; Graeber S; Herrmann W; Geisel J
    Am J Clin Nutr; 2016 Mar; 103(3):703-11. PubMed ID: 26864355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
    Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
    PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
    Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
    J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Gut Axis Involvement in Heart Failure: Focus on Trimethylamine N-oxide.
    Salzano A; Cassambai S; Yazaki Y; Israr MZ; Bernieh D; Wong M; Suzuki T
    Heart Fail Clin; 2020 Jan; 16(1):23-31. PubMed ID: 31735312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Research progress in the relationship between gut microbiota metabolite trimethylamine N-oxide and ischemic stroke.
    Fu Y; Hou X; Feng Z; Feng H; Li L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 49(3):447-456. PubMed ID: 38970519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients.
    Nie J; Xie L; Zhao BX; Li Y; Qiu B; Zhu F; Li GF; He M; Wang Y; Wang B; Liu S; Zhang H; Guo H; Cai Y; Huo Y; Hou FF; Xu X; Qin X
    Stroke; 2018 Sep; 49(9):2021-2028. PubMed ID: 30354996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole egg consumption increases plasma choline and betaine without affecting TMAO levels or gut microbiome in overweight postmenopausal women.
    Zhu C; Sawrey-Kubicek L; Bardagjy AS; Houts H; Tang X; Sacchi R; Randolph JM; Steinberg FM; Zivkovic AM
    Nutr Res; 2020 Jun; 78():36-41. PubMed ID: 32464420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and cardiovascular risk in patients with suspected functionally relevant coronary artery disease (fCAD).
    Amrein M; Li XS; Walter J; Wang Z; Zimmermann T; Strebel I; Honegger U; Leu K; Schäfer I; Twerenbold R; Puelacher C; Glarner N; Nestelberger T; Koechlin L; Ceresa B; Haaf P; Bakula A; Zellweger M; Hazen SL; Mueller C
    Clin Res Cardiol; 2022 Jun; 111(6):692-704. PubMed ID: 35220448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.
    Tang WH; Wang Z; Fan Y; Levison B; Hazen JE; Donahue LM; Wu Y; Hazen SL
    J Am Coll Cardiol; 2014 Nov; 64(18):1908-14. PubMed ID: 25444145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic Changes in Gut Microbiota-Derived Metabolite Trimethylamine-N-Oxide and Risk of Type 2 Diabetes Mellitus: Potential for Dietary Changes in Diabetes Prevention.
    Huang Y; Wu Y; Zhang Y; Bai H; Peng R; Ruan W; Zhang Q; Cai E; Ma M; Zhao Y; Lu Y; Zheng L
    Nutrients; 2024 May; 16(11):. PubMed ID: 38892643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut Colonization with Methanogenic Archaea Lowers Plasma Trimethylamine N-oxide Concentrations in Apolipoprotein e-/- Mice.
    Ramezani A; Nolin TD; Barrows IR; Serrano MG; Buck GA; Regunathan-Shenk R; West RE; Latham PS; Amdur R; Raj DS
    Sci Rep; 2018 Oct; 8(1):14752. PubMed ID: 30283097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults.
    Chen YM; Liu Y; Zhou RF; Chen XL; Wang C; Tan XY; Wang LJ; Zheng RD; Zhang HW; Ling WH; Zhu HL
    Sci Rep; 2016 Jan; 6():19076. PubMed ID: 26743949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
    Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
    J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
    Haissman JM; Haugaard AK; Ostrowski SR; Berge RK; Hov JR; Trøseid M; Nielsen SD
    BMC Infect Dis; 2017 Jun; 17(1):445. PubMed ID: 28645263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine-
    Cho CE; Aardema NDJ; Bunnell ML; Larson DP; Aguilar SS; Bergeson JR; Malysheva OV; Caudill MA; Lefevre M
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI.
    Matsuzawa Y; Nakahashi H; Konishi M; Sato R; Kawashima C; Kikuchi S; Akiyama E; Iwahashi N; Maejima N; Okada K; Ebina T; Hibi K; Kosuge M; Ishigami T; Tamura K; Kimura K
    Sci Rep; 2019 Aug; 9(1):11647. PubMed ID: 31406181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.
    Heianza Y; Ma W; Manson JE; Rexrode KM; Qi L
    J Am Heart Assoc; 2017 Jun; 6(7):. PubMed ID: 28663251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes: The Cardiovascular Health Study.
    Lemaitre RN; Jensen PN; Wang Z; Fretts AM; McKnight B; Nemet I; Biggs ML; Sotoodehnia N; de Oliveira Otto MC; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
    JAMA Netw Open; 2021 Aug; 4(8):e2122844. PubMed ID: 34448864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
    Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
    Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.